本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aclaris Therapeutics

3.60
-0.2300-6.01%
盘前:3.780.1754+4.87%08:40 EDT
成交量:342.90万
成交额:1,250.52万
市值:5.30亿
市盈率:-6.14
高:3.84
开:3.80
低:3.59
收:3.83
52周最高:6.60
52周最低:1.74
股本:1.47亿
流通股本:1.01亿
量比:0.51
换手率:3.40%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
净资产收益率:-59.10%
总资产收益率:-28.98%
市净率:4.25
市盈率(LYR):-6.79

数据加载中...

2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/14

重要事件披露

8-K - Current report
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/26

重要事件披露

8-K - Current report
2021/06/11

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/06/03

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

重要事件披露

8-K - Current report
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals